Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Liedtke C, Mazouni C, Hess KR, André F, Tordai A, Mejia JA, Symmans WF, Gonzalez-Angulo AM, Hennessy B, Green M, Cristofanilli M, Hortobagyi GN, Pusztai L. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008 Mar 10; 26(8):1275-81.
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols
-
Breast Neoplasms
-
Carcinoma, Ductal, Breast
-
Chemotherapy, Adjuvant
-
Female
-
Humans
-
Middle Aged
-
Neoadjuvant Therapy
-
Neoplasm Recurrence, Local
-
Neoplasm Staging
-
Neoplasm, Residual
-
Neoplasms, Hormone-Dependent
-
Prognosis
-
Prospective Studies
-
Receptor, ErbB-2
-
Receptors, Estrogen
-
Receptors, Progesterone
-
Survival Rate